Y-Mabs Therapeutics Stock (YMAB)
Track Y-Mabs Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
YMAB
Y-Mabs Therapeutics
$8.61
▼ -5.39 (-38.50%) past year
Market Cap
—
P/E Ratio
—
1Y Return
-38.50%
EPS (TTM)
—
Read the latest TheStreet Pro articles mentioning Y-Mabs Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning YMAB yet.
Daily Diary Mentions
0 mentionsNo diary mentions for YMAB yet.